Host Webcast News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sachem Capital Reports First Quarter 2024 Results – Revenues Grew 17 0% To $17 2 Million

Sachem Capital Reports First Quarter 2024 Results – Revenues Grew 17 0% To $17 2 Million
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJohn villanoSachem capital corpReal estate investment trustExchange commission onHaven bankCompany to host webcastNeedham bankFederal reserveHost webcastConference callSachem capitalChief executive officerWells fargo advisorsChurchill real estateNew haven bank

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc decPeter vozzoJacka khattarExchange commissionSupernus pharmaceuticalsCompany investor relationsSupernus pharmaceuticals incSecurities exchangeHost webcastReview interim dataOngoing open label phaseInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Belite bioJulie fallonJennifer wuBelite bio incCompany investor relatonsHost webcastDiscuss first quarterInvestor relatonsGeographic atrophyInvestor relations contact

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

01.05.2024 - - Achieved $14.1 Million in Net Revenue from Sales of COSELA (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib .

Jack baileyJohnw umsteadDrug administration onPepper bio incInvestor relations corporate communicationsTherapeutics incExchange commissionDrug administrationThat final analysisEvaluating overall survivalMetastatic triple negative breast cancerLate second quarterRunway expectedThird quarterHost webcastConference call

Heritage Global to Announce First Quarter 2024 Results and Host Webcast on Thursday, May 9, 2024

Heritage Global to Announce First Quarter 2024 Results and Host Webcast on Thursday, May 9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionHeritage global incWhile the companyAnnounce first quarterHost webcastEarnings conferenceInvestor relationsHeritage globalIndustrial assetsPrivate securities litigation reform act